Flaxseed oil nudges triglycerides and leaves cholesterol alone

Flaxseed oil is one of the most common plant-based omega-3 supplements, rich in alpha-linolenic acid and frequently taken in the hope of improving cholesterol and heart health. Individual trials of its effect on blood lipids have been small and inconsistent, leaving a genuine question over what, if anything, the supplement reliably changes. Blood fats matter because triglycerides and the cholesterol fractions are routine markers of cardiovascular risk. Pooling every randomised trial on the question is the way to find out whether the popular claims survive contact with the full evidence base, and at what dose any effect appears.

The authors systematically searched PubMed, Scopus, Google Scholar and Web of Science up to February 2025 for randomised controlled trials comparing flaxseed oil supplementation against a control group in adults. Thirty-six trials covering 1,959 participants qualified for inclusion. The team pooled the results using a random-effects model to estimate average changes in triglycerides, total cholesterol, LDL cholesterol and HDL cholesterol. They then ran subgroup analyses by trial length and participant characteristics, plus a dose-response analysis linking the amount of flaxseed oil and alpha-linolenic acid consumed to the lipid changes observed.

Across all trials, flaxseed oil lowered triglycerides by an average of 8.04 mg/dl, a statistically significant but modest change. Total cholesterol, LDL cholesterol and HDL cholesterol did not shift significantly overall. The subgroups told a more textured story: triglyceride reductions were larger in trials shorter than 12 weeks, at 16.86 mg/dl, and in obese participants, at 18.29 mg/dl, while HDL rose by 1.35 mg/dl in people starting at or below 40 mg/dl. The dose-response analysis suggested non-linear relationships between flaxseed oil and alpha-linolenic acid intake and both LDL and total cholesterol.

This pooled picture clarifies a messy literature: flaxseed oil's dependable lipid effect is on triglycerides, not cholesterol, and even that effect is modest on average. The finding sits awkwardly alongside marketing that positions the oil as a broad heart-health supplement. The hints of non-linear dose effects on LDL and total cholesterol keep a door open, and the authors say optimal dosing needs further research. It also remains unclear why shorter trials showed bigger triglyceride drops, which could reflect effects that fade over time or simply differences between the studies themselves.

If flaxseed oil is in your routine as a cholesterol fix, this is the evidence check: pooled across dozens of trials, it did not meaningfully move total, LDL or HDL cholesterol for the average adult. Where it earned its keep was triglycerides, with the largest average drops seen in obese participants, and a small HDL rise appeared only in people who started with low HDL. That makes it a narrow tool rather than a broad one. As ever with pooled averages, individual trials varied, so your own numbers could sit anywhere around these figures.